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Background: The development and evaluation of complex interventions in healthcare has obtained increased
awareness. The Medical Research Council’s (MRC) framework for the development and evaluation of complex
interventions and its update offers guidance for researchers covering the phases development, feasibility/piloting, and
evaluation. Comprehensive reporting of complex interventions enhances transparency and is essential for researchers
and policy-makers. Recently, a set of 16 criteria for reporting complex interventions in healthcare (CReDECI) was
published. The aim of this study is to evaluate the reporting quality in publications of complex interventions adhering
to either the first or the updated MRC framework, and to evaluate the applicability of CReDECI.
Methods: A systematic PubMed search was conducted. Two reviewers independently checked titles and abstracts for
inclusion. Trials on complex interventions adhering to the MRC framework and including an evaluation study in English and
German were included. For all included trials and for all publications which reported on phases prior to the evaluation study,
related publications were identified via forward citation tracking. The quality of reporting was assessed independently by
two reviewers using CReDECI. Inter-rater agreement and time needed to complete the assessment were determined.
Results: Twenty-six publications on eight trials were included. The number of publications per trial ranged from 1 to 6
(mean 3.25). The trials demonstrate a good reporting quality for the criteria referring to the development and feasibility/
piloting. For the criteria addressing the introduction of the intervention and the evaluation, quality of reporting varied
widely. Two trials fulfilled 7 and 8 items respectively, five trials fulfilled one to five items and one trial offered no information
on any item. The mean number of items with differing ratings per trial was two. The time needed to rate a trial ranged
from 30 to 90 minutes, depending on the number of publications.
Conclusions: Adherence to the MRC framework seems to have a positive impact on the reporting quality on the
development and piloting of complex interventions. Reporting on the evaluation could be improved. CReDECI is a practical
instrument to check the reporting quality of complex interventions and could be used alongside design-specific reporting
guidelines.
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Researching complex interventions in healthcare and
nursing has gained increased awareness following the pub-
lication of the UK Medical Research Council’s (MRC)
framework for development and evaluation of complex
interventions in 2000 [1] and its update in 2008 [2,3].
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reproduction in any medium, provided the orinterventions comprising several components which may
act either independently or inter-dependently [2]. How-
ever, there is no distinct boundary in the classification of
whether an intervention is complex or not. Characteristics
of complex interventions are, for example, the number of
different professions or organisational levels targeted by
the intervention and/or the degree of flexibility permitted
for the intervention [4].
While the first framework [1] implied a linear approach
comprising one preclinical and four clinical phases, theLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gives a better reflection of the flexibility or even non-
linearity of the research process. However, both versions
cover the same methodological steps of development,
piloting and evaluation of a complex intervention, and the
long-term implementation after the complex intervention
has demonstrated its effectiveness. Also, both frameworks
emphasise that the development of a complex intervention
should include a theoretical basis and a clear description
of the intended change processes. Prior to the evaluation,
the intervention should be piloted in the target setting and
its feasibility has to be tested. The evaluation study should
not only focus on effectiveness and cost-effectiveness but
also include the evaluation of the intended change process
by investigating the dose delivered, fidelity and reach of
the intervention (process evaluation) [5-7]. Thus, the de-
velopment and evaluation of complex interventions re-
quires several studies using different methods and study
designs [1-4].
Comprehensive reporting of all steps of the develop-
ment and evaluation of a complex intervention is crucial.
Sufficient information must be available for the judge-
ment of the intervention’s clinical benefits, for replica-
tion, or for adaption of an intervention to different
settings or countries [8-10]. However, several analyses
revealed shortcomings of the reporting of core aspects
of complex intervention research, e.g. regarding the the-
oretical basis and assumptions guiding the development
and piloting of the intervention, and the description of
intervention delivery [10-13]. These studies evaluated in-
terventions on defined topics, e.g. care of people after
stroke [13] and reduction of physical restraints in geriat-
ric care [12], or specific methodological aspects of re-
search on complex interventions [10,11]. An evaluation
of the reporting quality of a sample of systematically
identified complex interventions explicitly adhering to
the MRC framework has not been performed so far.
We have recently published a list of specific criteria
for reporting complex interventions in order to offer a
structured guidance for researchers and authors covering
the first three phases of the MRC framework [14]. In
contrast to other reporting guidelines (e.g. CONSORT),
CReDECI does not comprise design-specific items. The
development and evaluation of complex interventions
requires the use of different methodological approaches
and the criteria list includes only items covering these
specific methodological aspects [1-4,14]. Therefore,
CReDECI should be used alongside established study
design-specific reporting statements.
Employing the CReDECI criteria, the aim of the present
study was to evaluate the reporting quality of the develop-
ment and evaluation of complex interventions adhering to
the MRC framework. The second aim was to test the ap-
plicability of the criteria list.Methods
Literature search and study selection
All trials which adhered to the MRC framework were
eligible for inclusion. We use the term ‘trial’ for the en-
tire research process covering development, piloting and
evaluation of a complex intervention and all related pub-
lications or reports. Adherence to the MRC framework
was defined as citing either the first version [1] or the
updated framework [3] as methodological guide for the
development and evaluation of a complex intervention.
According to the aim of our study to test the applicabil-
ity of all CReDECI criteria, the included trials should
have undergone a controlled evaluation study.
The following inclusion criteria were defined: The
intervention was (I) labelled as ‘complex intervention’,
(II) developed and evaluated adhering to the MRC
framework, and (III) a controlled evaluation study was
published. All citations retrieved by database searching
and ‘snowballing’ techniques were screened independ-
ently by two reviewers (RM and GB) and checked for in-
clusion. We conducted a database search and used
snowballing techniques to identify relevant publications
since we expected several publications reporting on dif-
ferent phases of the same trial [15].
A systematic search in Medline (via PubMed) was
performed in April 2012. Medline was searched because
this database is the primary resource for clinicians and
researchers and most journals publishing evaluation
studies of health care interventions are covered. The
search was limited to German and English publications
of the last ten years. We explored several search strat-
egies to select the adequate search terms. Finally, we
used a combination of terms related to complex inter-
ventions and to the MRC framework (the complete
search strategy is described in Additional file 1). Since
we used additional snowballing technique to identify fur-
ther relevant publications, we believe the search strategy
employed to be sufficiently specific. In a second step, we
conducted forward citation tracking (via Scopus and
Google Scholar). For all citations identified by the data-
base search which reported on the development and/or
piloting of a complex intervention we checked whether
a publication of an evaluation study was available. In a
third step, we identified the associated publications of
the included trials, e.g. publications on the interventions’
development.
CReDECI
The CReDECI list [14] was developed based on a system-
atic literature review of methodological publications on
complex intervention research and the updated MRC
framework and reviewed by experts in the field. The criteria
list is divided into three sections: development (n = 6 items),
feasibility and piloting (n = 2 items), and introduction of the
Table 1 Overview of CReDECI
No Item Explanation
First phase – Development
1 Description of the intervention’s underlying theoretical considerations The theoretical basis of the intervention should be clearly stated. This
includes the theory on which the intervention is founded as well as, if
available, empirical evidence from studies in different settings or countries.
2 Description of all components of the intervention Complex interventions contain several interacting components, which
make up the intervention. All components should be clearly specified.
A graphical presentation of the components might be useful.
3 Rationale for the selection of the intervention’s components A description of the rationale for choosing the selected components
should be given. If formerly successfully proven components have been
excluded from the intervention, the rationale should be stated.
4 Illustration of any intended interactions between different components In some cases different components are designed to support or to
enhance the effect of other components. All expected reciprocal effects
should be explained.
5 Rationale for the aim/essential functions of the intervention’s
components, including the evidence whether the components are
appropriate for achieving this goal
It is necessary to describe the aim or essential function of the
intervention’s components rather than the content in detail, e.g. the
content of an education programme may differ more between various
countries than the aim or essential function.
6 Consideration of contextual factors and determinants of the setting in
the modelling of the intervention
The intervention should be tailored to the target setting. This includes
legal or political issues of a country as well as local conditions of the
participating centres.
Second phase – Feasibility and piloting
7 Information on pilot-testing The intervention should have been pilot-tested in order to determine
feasibility, acceptability, and practicability of the complex intervention.
The pilot test should take into account the key uncertainties which
have been identified during the development process.
8 In case of pilot-test: presentation of all relevant results and their
impact on the modelling of the final intervention
Results of the pilot test and any subsequent modification of the
intervention are highly relevant for other researchers in the field and
should be published.
Third phase – Introduction of the intervention and evaluation
9 Description of the control intervention (comparator) Information on the characteristics of the control intervention (e.g. usual
care or optimised usual care) should be given. It should be stated
whether components of the intervention were accessible for the
control group, whether a specific control intervention was delivered, or
whether the control group did not receive any intervention. If the
study took place in different centres, differences in usual care across
centres should also be described.
10 If the study was conducted in different clusters or centres: description
of a standardised implementation strategy throughout the centres
The implementation strategy should include methods to deal with the
local conditions, e.g. education of persons in charge for the
implementation, and methods to adjust the implementation process in
order to maintain a standardised implementation of the intervention.
11 Description of all materials or tools used for the implementation of the
intervention to allow a replication of the study
Complex interventions often comprise materials, e.g. brochures, checklists
or flyers. These materials might influence the interventions’ effects and
should be publicly accessible. In addition, the use of incentives may
influence study adherence and should therefore be stated.
12 Description of an evaluation of the implementation process Process evaluation is a prerequisite for determining the success of the
intervention’s implementation and should be an integral part of the
intervention’s evaluation.
13 Description of any deviation from the study protocol during the
implementation process
In order to replicate the study, information on the actual delivery of the
intervention and on any deviation from the study protocol concerning
the implementation should be reported. Deviations and necessary
adjustments of single components or the whole intervention during
the implementation process should be published. Adjustments may
have been necessary for a single centre, several clusters or the whole
intervention group.
14 Description of facilitators or barriers revealed by the process evaluation
which have influenced the interventions’ implementation
Any facilitators or barriers identified in the context of the process
evaluation should be described. Information on facilitators or barriers
may be derived both from staff and from the research team. Any
interpretation of facilitators or barriers, e.g. in the discussion section of the
publication, should be clearly separated in (1) information collected during
the process evaluation and (2) information derived from other studies.
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Table 1 Overview of CReDECI (Continued)
15 Description of unexpected interactions between components of the
intervention and the environment in which the intervention was
implemented
It should be stated if any change had been observed which may have
been caused by the implementation of the intervention.
16 Description of costs or required resources for the intervention’s
implementation
Information on costs or required resources necessary to implement the
intervention should be available in the publication or as reference to an
economic evaluation. Resources should include all expenses necessary
for the intervention’s implementation, e.g. personnel costs, material or
equipment.
Möhler et al. BMC Medical Research Methodology 2013, 13:125 Page 4 of 8
http://www.biomedcentral.com/1471-2288/13/125intervention and evaluation (n = 8 items). In contrast to
most of the available reporting guidelines, the CReDECI list
does not comprise items targeting a specific study-design,
since the development and evaluation of complex interven-
tions requires different study designs conducted subse-
quently or in parallel [2]. Instead, CReDECI focuses on
criteria covering the core elements that are specific for the
research of complex interventions. An overview of the cri-
teria and their explanation is presented in Table 1.
Data extraction
Two independent reviewers (RM, GB) applied CReDECI
to all publications related to the respective included trials.
For each item it was recorded whether sufficient informa-
tion was provided in any publication. In order to distin-
guish between sufficient and insufficient information, theRecords identified through 
database search 
(n = 157)
Records screened by title and a
(n = 274)
Trials included  
(n = 8)
Total number of publications in
(n = 26)
Full-text articles assessed for eli
(n = 18)
Addition
throu
Figure 1 Study selection flow diagram.raters assessed whether the information provided was
judged as comprehensive. The information to the individ-
ual items may have been included in several publications.
However, if a minimum of comprehensive information
was offered, the items were rated as fulfilled. We did not
assess the degree of comprehensibility.
The results of the independent ratings were compared
and agreement between both raters was checked. There-
after, differences in the ratings were discussed in order to
reach consensus. If results on planned parts of the trial were
missing (e.g. economic evaluation or process evaluation),
the corresponding author was contacted. The number of
trials fulfilling the criteria was calculated. The absolute
number of different ratings per trial was determined with
regard to inter-rater reliability as well as to the time spent
on completing the list (i.e. mean time of both raters).bstract 
Records excluded (title/abstract)
(n = 256)
cluded
gibility 
al records identified 
gh other sources 
(n = 117)
Records excluded (full text)
(n = 10)
Möhler et al. BMC Medical Research Methodology 2013, 13:125 Page 5 of 8
http://www.biomedcentral.com/1471-2288/13/125Results
A total of 274 publications were identified via database
search and forward citation tracking. Eight trials met the
inclusion criteria (Figure 1). Main reasons for exclusion
were that the interventions were not labelled as complex
or the studies did not adhere to the MRC framework. A
total of 26 publications were identified as reporting on
the eight included trials. In two cases, authors were
contacted for missing information. The mean number of
publications per trial was 3.25 (range 1 to 6). For one
trial, only one publication was available [16]. Four trials
were conducted in UK [16-19], two in Ireland [20,21]
and one in Germany [22] and the Netherlands [23], re-
spectively. Most of the complex interventions offered
structured approaches for improving the quality of care
for patients with chronic or complex conditions. Target
groups were people suffering from a stroke [16,19], can-
cer [18,22], coronary heart disease [20], or diabetes
mellitus Type 2 [21], patients at risk from prescription
and medication management errors in general practice
[17], and frail elderly people [23]. The interventions of-
fered improved care concepts or pathways [17,19,20,22]
or alternative or modified forms of information or sup-
port [16,18,21] e.g. peer support groups for patients and/
or their relatives [21]. Table 2 presents an overview of
the included trials and the underlying interventions. TheTable 2 – Overview of included complex interventions
Reference Aim
16 Evaluation of a family support organiser (FSO) service for stroke
and their carers
17 Evaluation of an information technology intervention for pharm
improve prescription safety and medication monitoring in gene
18 Evaluation of a nurse-delivered intervention for major depressiv
in patients with cancer
19 Evaluation of a patient and general practitioner systematic follo
intervention to improve risk factor management after stroke
20 Evaluation of a complex intervention for patients with establishe
coronary heart disease to improve clinical outcomes in general
21 Evaluation of peer support for improving biophysical and psych
outcomes for people with type 2 diabetes
22 Evaluation of an integrated quality of life diagnosis and therapy
in breast cancer patients
23 Evaluation of a fall prevention program to reduce the fall rate a
of falling in community-dwelling frail elderly and to alleviate sub
caregiver burdenquality of reporting on development and piloting of the
intervention was judged as good (Table 3). Seven out of
eight trials reported on all six items referring to the in-
tervention’s development [17-23] and one trial reported
on three items [16]. Most trials presented sufficient in-
formation on the feasibility and pilot phase. Concerning
the introduction and evaluation phase, the quality of
reporting varied. Only one trial reported on all eight
items [21] and one trial on seven items [17]. Five trials
reported on one to five items [18-20,22,23] and one trial
offered no information on any item [16].
The number of items with different ratings per trial
ranged from 0–5 with a mean of 2. The two reviewers dis-
agreed on 16 out of the total of 128 ratings (12.5%). The
time needed to rate a trial ranged from 30 to 90 minutes,
depending on the number of publications per trial.
Discussion
We identified a small number of trials whose authors ex-
plicitly stated having adhered to the MRC framework for
developing and evaluating complex interventions [2].
The quality of reporting in these trials was judged as
good for the intervention development and piloting
phases. Thus, our findings are contrary to previous ana-
lyses of the quality of reporting on complex interven-
tions [12,13,41]. However, the trials included in ourCountry Related publications
patients UK
acists to
ral practices.
UK Study protocol [24]
Report for the Department of Health,
Patient Safety Research Programme [25]
e disorders UK Pilot study [26]
Intervention development [27]
w-up UK Development of the intervention [28]
d
practice
Ireland Development of the intervention [29]
Development of the intervention [30]
Study protocol [31]
Process Evaluation [7]
Cost-effectiveness analysis [32]
osocial Ireland Development of the intervention [33]
Study protocol [34]
Cost-effectiveness analysis [35]
pathway Germany Study protocol [36]
Development of the intervention [37]
Pilot study [38]
nd fear
jective
The Netherlands Development of the intervention [39]
Results of the process evaluation [40]
Table 3 Results of the rating of the CReDECI items
[16] [17] [18] [19] [20] [21] [22] [23]
Development
1. Description of the intervention’s underlying theoretical considerations + + + + + + + +
2. Description of all components of the intervention + + + + + + + +
3. Rationale for the selection of the intervention’s components + + + + + + + +
4. Illustration of any intended interactions between different components - + + + + + + +
5. Rationale for the aim/essential functions of the intervention’s components, including the
evidence whether the components are appropriate for achieving this goal
- + + + + + + +
6. Consideration of contextual factors and determinants of the setting in the modelling of the
intervention
- + + + + + + +
Feasibility and piloting
7. Information on pilot-testing - + + + + + + +
8. In case of pilot-test: Presentation of all relevant results and their impact on the modelling
of the final intervention
n. a. + - + + + + +
Introduction of the intervention and evaluation
9. Description of the control intervention (comparator) - + - - + + + -
10. If the study was conducted in different clusters or centres: Description of a standardised
implementation strategy throughout the centres
- + n. a. - + + - n. a.
11. Description of all materials/ tools used for the implementation of the intervention to allow
a replication of the study
- + + + + + + -
12. Description of an evaluation of the implementation process - + - - +* + - +
13. Description of any deviation from the study protocol during the implementation process - + - - -* + - +
14. Description of facilitators or barriers revealed by the process evaluation which have influenced
the interventions’ implementation
- + - - - + - +
15. Description of unexpected interactions between components of the intervention and the
environment in which the intervention was implemented
- - - - - + - -
16. Description of costs or required resources for the intervention’s implementation - + + - + + - -*
+ Fulfilled; - not fulfilled; n. a. not applicable; * unpublished information delivered by study authors.
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since all trials confirmed adherence to the MRC frame-
work. For the evaluation phase, quality of reporting var-
ied. While two trials reported on nearly all criteria, six
trials offered information only on half of the items or
even less. These results confirm the findings from previ-
ous studies [9,11,12,42]. Only half of the trials included an
evaluation of the implementation process (CReDECI cri-
terion 12). However, this information is required in order
to get a deeper understanding of the effects of the evalu-
ation and to describe barriers and facilitators influencing
the intervention’s implementation. A process evaluation
should be an integral part of the evaluation of complex in-
terventions [2,5,6]. Only half of the trials offered informa-
tion on the characteristics of the care delivered in the
control group, which was often only described as usual or
standard care. The lack of information hampers the repli-
cation of studies and the adaption of the intervention to
different settings or countries [9,10].
The integration of the local context and detailed infor-
mation on the process evaluation has recently been
described as frequently underreported [43,44]. In oursample only a small number of trials included a process
evaluation but most trials offered information on the
integration of the context in the intervention’s develop-
ment. However, we did not assess the completeness of
the information provided.
The CReDECI list has proven its applicability and prac-
ticability. A high rate of agreement was reached by both re-
viewers. The time needed for assessment varied, depending
on the number of publications per trial. Since both re-
viewers were familiar with complex interventions research
and the MRC framework, application of the CReDECI list
by untrained users might be more time-consuming.
The currently available reporting guidelines specifically
address a defined study design, offering recommenda-
tions to improve the reporting of design-specific meth-
odological aspects [45]. The CReDECI list employs a
different approach since it comprises items covering
three phases of complex interventions’ research: devel-
opment, feasibility/piloting, and introduction of the
intervention and evaluation. However, we recommend
the additional use of design-specific reporting guidelines
alongside the CReDECI list. Currently, a CONSORT
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being developed [46]. This extension might be a valuable
supplementation to the CReDECI list.
Limitations of study
Although Medline includes a great number of journals
on healthcare research, the search in only one database
might be judged as limitation. Further publications not
indexed in Medline were identified through forward and
backward citation tracking. Thus, it is most likely that
we have identified the majority of publications on the
development and evaluation of complex intervention ex-
plicitly referring to the MRC framework.
In this study, we assessed whether the criteria were
fulfilled. Therefore, our analysis offers an overview about
relevant aspects of complex interventions’ development
and evaluation which were considered in the trials in-
cluded. However, this analysis offers no judgement on
the quality of the information provided.
We included only a small number of trials, since our
inclusion criteria were rather strict. Therefore, readers
must be aware that the results of our analysis do not
represent the reporting quality of publications on com-
plex interventions in general.
Conclusions
In this study, adhering to the MRC framework for the de-
velopment and evaluation of complex interventions seems
to have a positive impact on the quality of reporting of the
complex interventions’ development and feasibility/piloting.
These results are in contrast to former analysis [10-13].
Reporting on the evaluation phase could still be improved.
The CReDECI list seems to be a practical instrument for
checking the quality of reporting in publications on com-
plex interventions. It could be used alongside established
design-specific reporting guidelines such as the CON-
SORT statement. To further validate the CReDECI list, a
formal consensus process with researchers and stake-
holders is scheduled.
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